Is Cannabis a Gateway Drug? What the Research Actually Says

Is cannabis a gateway drug? It’s one of the most repeated claims in drug policy debate, and one of the most thoroughly tested. The short answer, based on the actual research rather than the slogan: no, not in the way the phrase implies — and the real explanation for why cannabis use and harder drug use often show up in the same people is more interesting than the myth.

What the Gateway Theory Actually Claims

The gateway hypothesis argues that using cannabis directly increases the likelihood of moving on to harder drugs — either through some biological priming effect, or through social exposure to a wider drug-using scene. It’s a causal claim: cannabis use, the theory says, is a meaningful step on the path toward something else.

What the Evidence Actually Shows

The National Academies of Sciences’ comprehensive review of cannabis research is one of the most rigorous assessments available, and its conclusions are more nuanced than either side of the gateway debate usually admits:

• There is only limited evidence of a statistical association between cannabis use and later tobacco use
• There is only limited evidence of a statistical association between cannabis use and changes in use of other licit or illicit substances
• There is moderate evidence of an association between cannabis use and later development of a substance use disorder

Note what’s missing from that list: strong evidence of direct causation. An association between cannabis use and other substance use clearly exists in the data — but association isn’t the same as cannabis causing what comes after.

The Better Explanation: Common Liability

The alternative explanation that’s gained the most traction among researchers is the common liability model. Instead of one drug causing use of the next, it argues that the same underlying factors — genetics, impulsivity, family history of addiction, environment, mental health, easy access to substances generally — make a person more likely to try cannabis, alcohol, tobacco, or harder drugs, independently of each other. One study cited in the National Academies review found that involvement with any of alcohol, tobacco, or cannabis in adolescence predicted later substance use disorders generally, not specifically progression from one to another.

Put simply: it’s not that cannabis opens a door to harder drugs. It’s that the same person who was going to try cannabis early was often already more likely to try other substances too, for reasons that have nothing to do with cannabis itself.

Why the Myth Persists

Part of the gateway theory’s staying power is that, for decades, cannabis was only available through the same illegal supply chains as harder drugs — meaning a cannabis user was, by necessity, exposed to a black market where other substances were also on offer. Spain’s Cannabis Social Club model exists in part because of exactly this logic: a legal, private, membership-based supply removes that specific exposure route, rather than relying on cannabis remaining a black-market product.

What This Means in Practice

None of this means cannabis use carries no risk — the moderate association with substance use disorder risk is real and worth taking seriously, particularly for younger or more vulnerable users. It just means the specific “gateway” framing — cannabis as a direct causal stepping stone — isn’t well supported by the evidence. If you’re weighing up club membership in Spain, the legal and practical details are covered in our membership rules guide.

FAQ

So is cannabis a gateway drug or not?

Not in the causal sense the phrase implies. The best available research finds only limited evidence that cannabis use itself drives later use of other substances — shared risk factors explain the pattern better than one drug leading to the next.

What is the common liability model?

It’s the idea that genetics, environment, mental health, and personality traits like impulsivity create a general vulnerability to substance use, making someone more likely to try multiple substances independently — rather than one substance causing the next.

Does legalising cannabis reduce any gateway effect?

It at least removes one plausible mechanism — exposure to a black market where harder drugs are also sold. Spain’s Cannabis Social Club model is a private, legal alternative to that exposure route.

Is there any real risk associated with cannabis use?

Yes — the same National Academies review found moderate evidence linking cannabis use to a later substance use disorder. The gateway myth being unsupported doesn’t mean cannabis use is risk-free.

Has this been studied specifically in Spain?

Yes — researchers have specifically tested the gateway hypothesis in national samples of Spanish adolescents, adding to the same broader body of evidence referenced above.